Medipharm Labs Archives | the deep dive

MediPharm Labs, Vivo Cannabis Slump After Announcing All-Stock Deal

MediPharm Labs (TSX: LABS) announced on Thursday an all-equity deal to acquire VIVO Cannabis (TSX: VIVO). The merger is expected

MediPharm Labs (TSX: LABS) appears to be slowly pulling back on its international endeavours. The firm this morning announced the

On May 16, Medipharm Labs (TSX: LABS) reported its first quarter financial results. The company reported revenues of $4.87 million,

Medipharm Labs (TSX: LABS) continues to suffer from management turnover. The company today announced that its CEO, Bryan Howcroft, will

Medipharm Labs (TSX: LABS) last night filed its fourth quarter financial results. The company managed to achieve an impressive feat,

Medipharm Labs (TSXV: LABS) appears to be following in the footsteps of competitor The Valens Company (TSX: VLNS), albeit with

Medipharm Labs (TSX: LABS) appears to be focused on cleaning up its balance sheet. The firm this morning indicated it

MediPharm Labs (TSX: LABS) this morning reported its third quarter financial results, posting revenues of $5.4 million for the quarter.

On August 16, Medipharm Labs (TSX: LABS) reported their second quarter financial results. The company reported $5.07 million in revenue,

Medipharm Labs (TSX: LABS) this morning continued to show its desperate need for effective leadership. The company posted yet another